Taysha Gene Therapies
TSHA
#6686
Rank
NZ$0.86 B
Marketcap
$4.21
Share price
13.30%
Change (1 day)
35.54%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2023 (TTM): -$3.75

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -$3.91. In 2022 the company made an earnings per share (EPS) of -$6.48 an increase over its 2021 EPS that were of -$7.90.

EPS history for Taysha Gene Therapies from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.75-42.22%
2022-$6.48-17.93%
2021-$7.9069.11%
2020-$4.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.72-4.80%๐Ÿ‡บ๐Ÿ‡ธ USA